Capital Advisors Ltd’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$645K Buy
4,442
+97
+2% +$13.4K 0.07% 156
2026
Q2
$558K Sell
4,345
-45
-1% -$5.27K 0.06% 175
2026
Q1
$528K Sell
4,390
-96
-2% -$11.1K 0.06% 167
2025
Q4
$472K Sell
4,486
-101
-2% -$9.48K 0.05% 182
2025
Q3
$385K Sell
4,587
-145
-3% -$11.9K 0.04% 200
2025
Q2
$375K Buy
4,732
+66
+1% +$5.25K 0.05% 195
2025
Q1
$419K Sell
4,666
-388
-8% -$36.2K 0.06% 175
2024
Q4
$503K Buy
5,054
+310
+7% +$32K 0.06% 157
2024
Q3
$539K Sell
4,744
-208
-4% -$24.7K 0.07% 151
2024
Q2
$613K Buy
4,952
+263
+6% +$33.9K 0.08% 137
2024
Q1
$619K Buy
4,689
+146
+3% +$18K 0.08% 136
2023
Q4
$495K Sell
4,543
-29
-0.6% -$3.01K 0.07% 155
2023
Q3
$471K Sell
4,572
-41
-0.9% -$4.42K 0.07% 151
2023
Q2
$532K Buy
4,613
+2,083
+82% +$237K 0.08% 144
2023
Q1
$269K Sell
2,530
-1,422
-36% -$154K 0.04% 197
2022
Q4
$284K Buy
3,952
+1,685
+74% +$172K 0.05% 187
2022
Q3
$195K Sell
2,267
-68
-3% -$6.07K 0.04% 234
2022
Q2
$213K Sell
2,335
-101
-4% -$8.95K 0.04% 218
2022
Q1
$200K Buy
2,436
+139
+6% +$11K 0.03% 230
2021
Q4
$176K Buy
2,297
+245
+12% +$19.5K 0.03% 240
2021
Q3
$154K Hold
2,052
– – 0.03% 242
2021
Q2
$160K Hold
2,052
– – 0.03% 226
2021
Q1
$158K Hold
2,052
– – 0.03% 203
2020
Q4
$168K Hold
2,052
– – 0.04% 191
2020
Q3
$170K Hold
2,052
– – 0.04% 175
2020
Q2
$159K Sell
2,052
-526
-20% -$41.5K 0.04% 175
2020
Q1
$198K Buy
2,578
+129
+5% +$10.6K 0.06% 147
2019
Q4
$223K Buy
2,449
+120
+5% +$10.3K 0.06% 146
2019
Q3
$196K Hold
2,329
– – 0.05% 146
2019
Q2
$195K Buy
2,329
+200
+9% +$16K 0.06% 146
2019
Q1
$177K Hold
2,129
– – 0.05% 160
2018
Q4
$163K Hold
2,129
– – 0.05% 160
2018
Q3
$151K Hold
2,129
– – 0.04% 173
2018
Q2
$129K Hold
2,129
– – 0.04% 157
2018
Q1
$116K Hold
2,129
– – 0.04% 165
2017
Q4
$120K Hold
2,129
– – 0.04% 160
2017
Q3
$136K Hold
2,129
– – 0.05% 146
2017
Q2
$136K Hold
2,129
– – 0.05% 146
2017
Q1
$135K Hold
2,129
– – 0.05% 140
2016
Q4
$125K Hold
2,129
– – 0.05% 138
2016
Q3
$133K Hold
2,129
– – 0.06% 132
2016
Q2
$123K Hold
2,129
– – 0.06% 135
2016
Q1
$113K Hold
2,129
– – 0.06% 134
2015
Q4
$112K Hold
2,129
– – 0.06% 131
2015
Q3
$105K Hold
2,129
– – 0.06% 129
2015
Q2
$121K Buy
2,129
+146
+7% +$8.58K 0.06% 124
2015
Q1
$114K Buy
1,983
+50
+3% +$2.97K 0.06% 129
2014
Q4
$110K Hold
1,933
– – 0.06% 120
2014
Q3
$114K Hold
1,933
– – 0.06% 124
2014
Q2
$112K Hold
1,933
– – 0.06% 129
2014
Q1
$110K Hold
1,933
– – 0.06% 132
2013
Q4
$97K Hold
1,933
– – 0.06% 112

Other funds holding MRK

Capital Advisors Ltd's MRK Position: Q3 2026 in Review

Capital Advisors Ltd increased its Merck (MRK) stake by 2.2% in Q3 2026, buying an estimated $13.4K and bringing the position to 4,442 shares worth $645K. The position accounts for 0.07% of the portfolio, ranked #156.

Capital Advisors Ltd first reported a position in MRK in Q4 2013 and has held it in 52 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Capital Advisors Ltd held 4,442 shares of Merck worth $645K as of Q3 2026.
  • Capital Advisors Ltd bought 97 Merck shares in Q3 2026, an estimated $13.4K.
  • Merck made up 0.07% of Capital Advisors Ltd's portfolio in Q3 2026, its #156 holding.
  • Capital Advisors Ltd first reported a position in Merck in Q4 2013 and has held it in 52 quarters since.
  • 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.